Results 21 to 30 of about 162,747 (308)

Absolute oral bioavailability of ciprofloxacin [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 1986
We evaluated the absolute bioavailability of ciprofloxacin, a new quinoline carboxylic acid, in 12 healthy male volunteers. Doses of 200 mg were given to each of the volunteers in a randomized, crossover manner 1 week apart orally and as a 10-min intravenous infusion.
G L, Drusano   +5 more
openaire   +2 more sources

Oral diacetylmorphine (heroin) yields greater morphine bioavailability than oral morphine: bioavailability related to dosage and prior opioid exposure [PDF]

open access: yes, 2008
AIMS: In the Swiss heroin substitution trials, patients are treated with self-administered diacetylmorphine (heroin). Intravenous administration is not possible in patients that have venosclerosis.
Eich-Höchli, D   +9 more
core   +1 more source

Cow Milk and Intestinal Epithelial Cell-derived Extracellular Vesicles as Systems for Enhancing Oral Drug Delivery

open access: yesPharmaceutics, 2020
Ingestion is the preferred way for drug administration. However, many drugs have poor oral bioavailability, warranting the use of injections. Extracellular vesicles (EVs) from cow milk have shown potential utility in improving oral drug bioavailability ...
Greta Carobolante   +3 more
doaj   +1 more source

Phytosomes as a Plausible Nano-Delivery System for Enhanced Oral Bioavailability and Improved Hepatoprotective Activity of Silymarin

open access: yesPharmaceuticals, 2022
Silymarin, a phyto-constituent derived from the plant Silybum marianum, has been widely acknowledged for its hepatoprotective activities. Nevertheless, its clinical utility is adversely hampered by its poor water-solubility and its limited oral ...
Ravi Gundadka Shriram   +6 more
doaj   +1 more source

A novel oral prodrug-targeting transporter MCT 1: 5-fluorouracil-dicarboxylate monoester conjugates

open access: yesAsian Journal of Pharmaceutical Sciences, 2019
Monocarboxylate transporter 1 (MCT1) is responsible for oral absorption of short-chain monocarboxylic acids from small intestine, hence, it's likely to serve as an ideal design target for the development of oral prodrugs.
Yixin Sun   +7 more
doaj   +1 more source

Prediction of absolute bioavailability of medicines in children: based on predicted pediatric clearance from adults [PDF]

open access: yesExploration of Drug Science
Aim: The objective of this study was to evaluate the predictive performance of a proposed method to predict absolute bioavailability of medicines in children (infants to adolescents).
Iftekhar Mahmood
doaj   +1 more source

Oral Bioavailability Enhancement of Raloxifene with Nanostructured Lipid Carriers

open access: yesNanomaterials, 2020
Raloxifene hydrochloride (RLX) shows poor bioavailability (90%). The objective of this study was to develop nanostructured lipid carriers (NLCs) for RLX to enhance its bioavailability.
Aditya Murthy   +3 more
doaj   +1 more source

An Orally Bioavailable (Mice) Prodrug of Glutathione [PDF]

open access: yesAntioxidants, 2021
Cysteine-glutathione mixed disulfide (CySSG), a prodrug of glutathione (GSH) --the “Master Antioxidant”, was found to be orally bioavailable in mice, and protected against a toxic dose of acetaminophen. If oral bioavailability can also be demonstrated in humans, this suggests a wide range of applicability for CySSG.
Herbert T. Nagasawa   +3 more
openaire   +4 more sources

Antituberculosis Macozinone Extended-Release Tablets To Enhance Bioavailability: a Pilot Pharmacokinetic Study in Beagle Dogs

open access: yesMicrobiology Spectrum, 2023
Macozinone (MCZ; PBTZ169) is a first-in-class antituberculosis clinical-stage benzothiazinone-based drug candidate. Although its efficacy and safety have been strongly proven in several preclinical and clinical studies, the physicochemical and ...
Angela Koryakova   +5 more
doaj   +1 more source

Recent advances in improving oral drug bioavailability by cocrystals [PDF]

open access: yesBioImpacts, 2018
Introduction: Oral drug delivery is the most favored route of drug administration. However, poor oral bioavailability is one of the leading reasons for insufficient clinical efficacy.
Shahram Emami   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy